WFDC2 and ovarian benign neoplasm: We evaluated the ability to distinguish between benign and non-benign ovarian tumors using the AUC of CA125, HE4, and C5a within serum sEV, as well as the combined index OCS with serum CA125, HE4, and ROMA indices.